The inhibitors of Cnr2 receptor had the ability to partially counteract the anti-inflammatory effects of CBD in vitro, but no significant phenotypical and pathological differences were observed between wild type PAH and Cnr2-/- PAH mice. Here, CNR2 is linked to pulmonary arterial hypertension.